Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products it ships into the United States are offset by its exports of U.S.-made drugs ...

To strengthen its U.S. presence, Roche is building up inventory, ramping up production at three of its U.S. plants and relocating one manufacturing site to the U.S. through a technology transfer, its ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

Also, various other major tech firms have announced investments on U.S. soil this year, including Apple's $500 billion for manufacturing and training, TSMC's $100 billion for chip making, and Nvidia's ...

The investment plans include new R&D sites in four US states and creating more than 12,000 jobs, according to the Swiss ...

Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years. Roche announced ...

Drugmakers Roche and Regeneron said they will spend billions of dollars to expand U.S. manufacturing, the latest pharmaceutical companies to commit to American production as new and future tariffs ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States ...

During the last three months, 6 analysts shared their evaluations of ANI Pharmaceuticals ANIP, revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their ...